Country, language and currency
- Social bookmarks:
- Testimonials
-
Read more »
Our billing is certified by:
-
- New Combo Allergy Drug Approved by FDA - Medscape
- New Combo Allergy Drug Approved by FDAMedscapeDymista (Meda Pharmaceuticals) nasal spray combines fluticasone propionate (Flonase, GlaxoSmithKline) and azelastine hydrochloride (Astepro, Astelin, Meda Pharmaceuticals)
- FDA approves new treatment for seasonal allergic rhinitis - Clinical Advisor
- FDA approves new treatment for seasonal allergic rhinitisClinical AdvisorThe FDA has approved azelastine HCI and fluticasone propionate nasal spray (Dymista, Meda) to treat seasonal allergic rhinitis
- FDA approves Meda allergy combo Dymista - Pharma Times
- FDA approves Meda allergy combo DymistaPharma TimesThe approval from the US Food and Drug Administration for Dymista (azelastine and fluticasone) is based on 'several studies involving more than 4000 patients', including one long-term safety study with more than 600 participants
- Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year ... - MarketWatch (press release)
- Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year
- FDA Sends Letter to Meda Pharmaceuticals Over Astepro Telephone Script - PharmaLive.com (press release)
- FDA Sends Letter to Meda Pharmaceuticals Over Astepro Telephone ScriptPharmaLive
